Free Trial

Molecular Partners (MOLN) Short Interest Ratio & Short Volume

Molecular Partners logo
$6.06
-0.06 (-0.98%)
(As of 11/4/2024 ET)

Molecular Partners Short Interest Data

Molecular Partners (MOLN) has a short interest of 33,500 shares. This marks a 7.37% increase in short interest from the previous month. The short interest ratio (days to cover) is 1.4, indicating that it would take 1.4 days of the average trading volume of 39,274 shares to cover all short positions.

Current Short Interest
33,500 shares
Previous Short Interest
31,200 shares
Change Vs. Previous Month
+7.37%
Dollar Volume Sold Short
$165,825.00
Short Interest Ratio
1.4 Days to Cover
Last Record Date
October 15, 2024
Outstanding Shares
36,690,000 shares
Percentage of Shares Shorted
0.09%
Today's Trading Volume
1,434 shares
Average Trading Volume
39,274 shares
Today's Volume Vs. Average
4%
Short Selling Molecular Partners?
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook

Sign up to receive the latest short interest report for Molecular Partners and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

MOLN Short Interest Over Time

MOLN Days to Cover Over Time

MOLN Percentage of Float Shorted Over Time

Molecular Partners Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
10/15/202433,500 shares $165,825.00 +7.4%N/A1.4 $4.95
9/30/202431,200 shares $158,717.52 +4.4%N/A1.9 $5.09
9/15/202429,900 shares $156,078.00 +0.3%N/A1.7 $5.22
8/31/202429,800 shares $169,264.00 -8.9%N/A0.8 $5.68
8/15/202432,700 shares $206,886.36 -53.2%N/A0.9 $6.33
7/31/202469,900 shares $629,100.00 +6.2%N/A1.9 $9.00
7/15/202465,800 shares $413,882.00 -23.8%N/A2.4 $6.29
6/30/202486,300 shares $623,949.00 -25.1%N/A3.2 $7.23
6/15/2024115,200 shares $779,904.00 +134.2%N/A4.6 $6.77
5/31/202449,200 shares $177,120.00 No ChangeN/A7.5 $3.60
5/15/202449,200 shares $182,532.00 -8.0%N/A13.7 $3.71
4/30/202453,500 shares $202,283.50 -5.1%N/A15.7 $3.78
4/15/202456,400 shares $222,780.00 +17.8%N/A18.8 $3.95
3/31/202447,900 shares $201,180.00 -2.2%N/A9.8 $4.20
3/15/202449,000 shares $194,040.00 -12.5%N/A3.7 $3.96
2/29/202456,000 shares $240,800.00 -7.6%N/A4.1 $4.30
2/15/202460,600 shares $282,093.00 +3.6%N/A4.5 $4.66
1/31/202458,500 shares $279,630.00 -13.7%N/A4.4 $4.78
1/15/202467,800 shares $323,406.00 +1,132.7%N/A4.9 $4.77
12/31/20235,500 shares $22,989.45 -11.3%N/A0.4 $4.18
12/15/20236,200 shares $26,102.00 -39.2%N/A2.4 $4.21
11/30/202310,200 shares $42,840.00 +117.0%N/A2.6 $4.20
11/15/20234,700 shares $20,774.00 -4.1%N/A1 $4.42
10/31/20234,900 shares $17,297.00 +2.1%N/A0.9 $3.53
10/15/20234,800 shares $20,884.32 -34.3%N/A1 $4.35
9/30/20237,300 shares $30,222.00 -73.1%N/A1.6 $4.14
9/15/202327,100 shares $123,576.00 +173.7%N/A6 $4.56
8/31/20239,900 shares $59,301.00 +135.7%N/A3.5 $5.99
8/15/20234,200 shares $24,822.00 +23.5%N/A2.1 $5.91
7/31/20233,400 shares $20,349.00 +21.4%N/A2.6 $5.99
7/15/20232,800 shares $18,312.00 -46.2%N/A2.3 $6.54
6/30/20235,200 shares $32,344.00 -3.7%N/A4 $6.22
6/15/20235,400 shares $35,748.00 +54.3%N/A4.2 $6.62
5/31/20233,500 shares $22,470.00 -31.4%N/A2.1 $6.42
5/15/20235,100 shares $33,762.51 -42.7%N/A3.6 $6.62
4/30/20238,900 shares $58,651.00 -60.4%N/A4.9 $6.59
4/15/202322,500 shares $146,925.00 +9.2%N/A10.2 $6.53
3/31/202320,600 shares $124,380.74 +32.1%N/A9.4 $6.04
3/15/202315,600 shares $91,416.00 +2.6%N/A6.2 $5.86
2/28/202315,200 shares $95,000.00 No ChangeN/A4.8 $6.25
This company will win the AI race (Ad)

Rome wasn’t built in a day… But there is another lesser-known type of keystone, one that plays an equally critical role in supporting the most revolutionary technology the world’s ever seen… artificial intelligence. And without it, the entire AI industry would collapse.

You must read this new presentation from Porter Stansberry.
2/15/202315,200 shares $97,584.00 -2.6%N/A4.5 $6.42
1/31/202315,600 shares $100,620.00 -1.3%N/A3 $6.45
1/15/202315,800 shares $107,484.24 +22.5%N/A2.8 $6.80
12/30/202212,900 shares $84,495.00 +10.3%N/A1.7 $6.55
12/15/202211,700 shares $80,028.00 -14.0%N/A1.4 $6.84
11/30/202213,600 shares $87,040.00 +9.7%N/A1.5 $6.40
11/15/202212,400 shares $86,056.00 -2.4%N/A1.3 $6.94
10/31/202212,700 shares $79,122.27 -7.3%N/A1.3 $6.23
10/15/202213,700 shares $83,433.00 -12.7%N/A1.5 $6.09
9/30/202215,700 shares $105,033.00 -20.7%N/A1.7 $6.69
9/15/202219,800 shares $124,938.00 -26.4%N/A1.9 $6.31
8/31/202226,900 shares $157,634.00 -9.4%N/A2 $5.86
8/15/202229,700 shares $201,663.00 -34.3%N/A1.6 $6.79
7/31/202245,200 shares $279,788.00 +5.6%N/A1.6 $6.19
7/15/202242,800 shares $270,496.00 -3.4%N/A1.4 $6.32
6/30/202244,300 shares $300,354.00 +13.3%N/A1.5 $6.78
6/15/202239,100 shares $265,489.00 +141.4%N/A1.4 $6.79
5/31/202216,200 shares $123,120.00 +76.1%N/A0.6 $7.60
5/15/20229,200 shares $63,480.00 -47.4%N/A0.4 $6.90
4/30/202217,500 shares $140,875.00 +14.4%N/A1.8 $8.05
4/15/202215,300 shares $292,230.00 -26.8%N/A1.4 $19.10
3/31/202220,900 shares $429,495.00 -54.5%N/A0.5 $20.55
3/15/202245,900 shares $941,409.00 -26.7%N/A1 $20.51
2/28/202262,600 shares $1.51 million -19.4%N/A1.3 $24.15
2/15/202277,700 shares $2.05 million -5.0%N/A1.5 $26.37
1/31/202281,800 shares $2.24 million -40.3%N/A1.4 $27.35
1/15/2022137,000 shares $4.37 million +1,081.0%N/A2.4 $31.89
12/31/202111,600 shares $222,488.00 -32.6%N/A0.4 $19.18
12/15/202117,200 shares $270,040.00 +45.8%N/A0.6 $15.70
11/30/202111,800 shares $165,318.00 -19.2%N/A0.5 $14.01
11/15/202114,600 shares $215,934.00 +78.1%N/A0.7 $14.79
10/29/20218,200 shares $152,602.00 -6.8%N/A0.4 $18.61
10/15/20218,800 shares $174,240.00 -59.5%N/A0.4 $19.80
9/30/202121,700 shares $425,537.00 +14.8%N/A0.9 $19.61
9/15/202118,900 shares $381,024.00 -18.2%N/A0.6 $20.16
8/31/202123,100 shares $484,176.00 +75.0%N/A0.3 $20.96
8/13/202113,200 shares $255,552.00 No ChangeN/A0.1 $19.36

MOLN Short Interest - Frequently Asked Questions

What is Molecular Partners' current short interest?

Short interest is the volume of Molecular Partners shares that have been sold short but have not yet been closed out or covered. As of October 15th, traders have sold 33,500 shares of MOLN short. Learn More on Molecular Partners' current short interest.

What is a good short interest ratio for Molecular Partners?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. MOLN shares currently have a short interest ratio of 1.0. Learn More on Molecular Partners's short interest ratio.

Is Molecular Partners' short interest increasing or decreasing?

Molecular Partners saw a increase in short interest during the month of October. As of October 15th, there was short interest totaling 33,500 shares, an increase of 7.4% from the previous total of 31,200 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

How does Molecular Partners' short interest compare to its competitors?

Here is how the short interest of companies compare to Molecular Partners: Kodiak Sciences Inc. (2.94%), Adaptimmune Therapeutics plc (2.17%), Adverum Biotechnologies, Inc. (12.04%), Karyopharm Therapeutics Inc. (14.12%), Omega Therapeutics, Inc. (29.49%), BioXcel Therapeutics, Inc. (1.41%), Renalytix Plc (0.46%), REGENXBIO Inc. (10.10%), Pliant Therapeutics, Inc. (11.43%), Tyra Biosciences, Inc. (8.25%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($4.14 billion), AppLovin Co. ($3.15 billion), Paychex, Inc. ($2.69 billion), Nu Holdings Ltd. ($2.48 billion), Cencora, Inc. ($2.24 billion), International Paper ($2.04 billion), Tractor Supply ($1.96 billion), Coinbase Global, Inc. ($1.93 billion), Moderna, Inc. ($1.91 billion), and SoFi Technologies, Inc. ($1.84 billion). View all of the most shorted stocks.

What does it mean to sell short Molecular Partners stock?

Short selling MOLN is an investing strategy that aims to generate trading profit from Molecular Partners as its price is falling. MOLN shares are trading down $0.06 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Molecular Partners?

A short squeeze for Molecular Partners occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of MOLN, which in turn drives the price of the stock up even further.

How often is Molecular Partners' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including MOLN, twice per month. The most recent reporting period available is October, 15 2024.




This page (NASDAQ:MOLN) was last updated on 11/5/2024 by MarketBeat.com Staff
From Our Partners